Implementing Personal Health Records to Promote Evidence-Based Cancer Screening
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02138448 |
Recruitment Status :
Completed
First Posted : May 14, 2014
Last Update Posted : June 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cancer Health Promotion | Behavioral: Interactive Preventive Health Record | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 46 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Implementing Personal Health Records to Promote Evidence-Based Cancer Screening |
Actual Study Start Date : | January 2017 |
Actual Primary Completion Date : | May 15, 2020 |
Actual Study Completion Date : | May 15, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention practices
Intervention practices will implement an interactive preventive health record in addition to their standard personal health record functionality.
|
Behavioral: Interactive Preventive Health Record
The interactive preventive healthcare record (IPHR) is a patient-centered application that links patients to their clinician's record, explains information in lay language, displays tailored recommendations and educational resources, and makes preventive care actionable.
Other Name: MyPreventiveCare |
No Intervention: Control practices
Control practices will continue to field their existing personal health record
|
- Percent of patients who are up-to-date with recommended cancer screening tests in intervention versus control practices. [ Time Frame: 1 year ]The percent of eligible patients who are up-to-date with all indicated cancer screenings (all-or-none measure).
- Shared decision-making outcomes (knowledge, communication, decisional conflict, and decision control) reported by patients in intervention versus control practices [ Time Frame: 1 year ]
To assess shared decision making a composite score based on the following measures will be calculated.
- Knowledge gained will be measured by using the IPHR, we will use questions from NCI's Health Information National Trends Survey (HINTS).
-
To assess whether the IPHR helps patients weigh values regarding risks and benefits 2 measures will be used: (a) process (patient-clinician communication) and (b) patient perception (decisional conflict).
- Communication will be measured by using questions from AHRQ's Consumer Assessment of HealthCare Providers and Systems (CAHPS) survey.
- O'Connor's low literacy decisional conflict scale will be used to measure decisional conflict.
- To assess whether the IPHR fosters decision-making engagement at the desired level, Degner's locus of control metric will be used.
- To assess whether cancer screening rates differ for disadvantaged patients, defined as minorities and Medicaid beneficiaries. [ Time Frame: 1 year ]The difference in delivery of preventive services (Effectiveness) will be calculated for disadvantaged patients and the general population, using a two-level mixed-effects logistic regression for the all-or-none, composite, and individual screening tests.
- To assess whether shared decision-making differ for disadvantaged patients, defined as minorities and Medicaid beneficiaries. [ Time Frame: 1 year ]
To assess shared decision making a composite score based on the following measures will be calculated.
- Knowledge gained will be measured by using the IPHR, we will use questions from NCI's Health Information National Trends Survey (HINTS).
-
To assess whether the IPHR helps patients weigh values regarding risks and benefits 2 measures will be used: (a) process (patient-clinician communication) and (b) patient perception (decisional conflict).
- Communication will be measured by using questions from AHRQ's Consumer Assessment of HealthCare Providers and Systems (CAHPS) survey.
- O'Connor's low literacy decisional conflict scale will be used to measure decisional conflict.
- To assess whether the IPHR fosters decision-making engagement at the desired level, Degner's locus of control metric will be used.
These scores will be calculated for disadvantaged patients (minorities and Medicaid patients) and the general population that use the IPHR, then compared.
- To assess whether perceptions of the technology differ for disadvantaged patients, defined as minorities and Medicaid beneficiaries. [ Time Frame: 1 year ]Post-implementation patient phone interviews will be conducted then analyzed using grounded-theory approach to understand disadvantaged patients' perceptions of and experience with the IPHR. These results will be compared to the phone interviews done with patients from the general population.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Practices in a practice based research network participating in our study that have an existing patient health record
- Patients that attend our study practices
Exclusion Criteria:
Practices without a patient health record

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02138448
United States, New Mexico | |
University of New Mexico-RIOS Net | |
Albuquerque, New Mexico, United States, 87131 | |
United States, Oregon | |
OCHIN | |
Portland, Oregon, United States, 97201 | |
United States, Virginia | |
Virginia Commonwalth University | |
Richmond, Virginia, United States, 23298 |
Principal Investigator: | Alexander H Krist, MD, MPH | Virginia Commonwalth University |
Responsible Party: | Virginia Commonwealth University |
ClinicalTrials.gov Identifier: | NCT02138448 |
Other Study ID Numbers: |
HM15307 1R01CA168795-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | May 14, 2014 Key Record Dates |
Last Update Posted: | June 11, 2020 |
Last Verified: | June 2020 |
Cancer Screenings Health Information Technology Patient Health Record Preventive Services |